COMMITMENTS AND CONTINGENCIES - Narrative (Details) $ in Thousands |
1 Months Ended | 6 Months Ended | 12 Months Ended | |||||
|---|---|---|---|---|---|---|---|---|
|
Nov. 15, 2021
shares
|
Dec. 01, 2020
shares
|
Jun. 30, 2021
shares
|
Jul. 31, 2020
shares
|
Jun. 30, 2021
shares
|
Dec. 31, 2021
shares
|
Dec. 31, 2020
shares
|
Dec. 31, 2016
CAD ($)
item
shares
|
|
| Commitments and Contingencies | ||||||||
| Shares issued | 909,262 | 3,271,541 | 156,032 | 25,185 | ||||
| Performance Shares | ||||||||
| Commitments and Contingencies | ||||||||
| Number of executives | item | 2 | |||||||
| EBITDA threshold | $ | $ 7,500 | |||||||
| Shares issued | 1,000,000 | 1,200,000 | ||||||
| Restricted stock award agreements, vested | 1,000,000 | |||||||
| Trailing days for average closing price | 30 days | |||||||
| Number of performances shares settled | 200,000 | 1,000,000 | ||||||
| X | ||||||||||
- Definition Number of executives. No definition available.
|
| X | ||||||||||
- Definition Number of performances shares settled. No definition available.
|
| X | ||||||||||
- Definition Threshold amount of earnings before interest, tax, depreciation and amortization (EBITDA). No definition available.
|
| X | ||||||||||
- Definition Trailing days for average closing price. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|